clinical trial · NCT00685698
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
TaiGen Biotechnology Co., Ltd.·phase2·completed·n = 40
Diabetic Foot InfectionsTG-873870 (Nemonoxacin)
brief summary
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
started
Jun 1, 2008
primary completion
Apr 1, 2009
completion
Jun 1, 2009
last updated
Jul 1, 2025
detailed description
This study will assess the safety and efficacy of TG-873870 (Nemonoxacin) in patients with Diabetic Foot Infections. Pharmacokinetic (PK) and pharmacodynamic (PD) assessment will be conducted in a subgroup of eight consenting patients.
official title
An Open-Label, Single-Arm, Multi-Center Study of TG-873870 for Treating Patients With Diabetic Foot Infections of Mild to Moderate Severity Associated With Gram-Positive Pathogens
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol